GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invictus MD Strategies Corp (OTCPK:IVITF) » Definitions » Beneish M-Score

Invictus MD Strategies (Invictus MD Strategies) Beneish M-Score : 0.00 (As of Apr. 28, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Invictus MD Strategies Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Invictus MD Strategies's Beneish M-Score or its related term are showing as below:

During the past 5 years, the highest Beneish M-Score of Invictus MD Strategies was 0.00. The lowest was 0.00. And the median was 0.00.


Invictus MD Strategies Beneish M-Score Historical Data

The historical data trend for Invictus MD Strategies's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invictus MD Strategies Beneish M-Score Chart

Invictus MD Strategies Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19
Beneish M-Score
- - -2.03 -2.62 -2.79

Invictus MD Strategies Quarterly Data
Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.18 -2.79 -5.29 -2.28 -2.51

Competitive Comparison of Invictus MD Strategies's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Invictus MD Strategies's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invictus MD Strategies's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Invictus MD Strategies's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Invictus MD Strategies's Beneish M-Score falls into.



Invictus MD Strategies Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Invictus MD Strategies for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8137+0.528 * 0.9806+0.404 * 1.0661+0.892 * 2.3682+0.115 * 2.2353
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.4596+4.679 * -0.096972-0.327 * 1.9947
=-1.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Oct19) TTM:Last Year (Oct18) TTM:
Total Receivables was $5.11 Mil.
Revenue was 0.636 + 1.882 + 1.2 + 2.74 = $6.46 Mil.
Gross Profit was 0.187 + 0.397 + 0.918 + 0.855 = $2.36 Mil.
Total Current Assets was $9.16 Mil.
Total Assets was $94.69 Mil.
Property, Plant and Equipment(Net PPE) was $23.62 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.83 Mil.
Selling, General, & Admin. Expense(SGA) was $19.10 Mil.
Total Current Liabilities was $9.53 Mil.
Long-Term Debt & Capital Lease Obligation was $6.87 Mil.
Net Income was -4.998 + -9.419 + -3.47 + -10.683 = $-28.57 Mil.
Non Operating Income was -0.128 + -3.799 + -0.192 + -4.424 = $-8.54 Mil.
Cash Flow from Operations was -1.358 + -1.014 + -2.811 + -5.662 = $-10.85 Mil.
Total Receivables was $2.65 Mil.
Revenue was 0.804 + 0.351 + 1.023 + 0.549 = $2.73 Mil.
Gross Profit was 0.2 + 0.123 + 0.443 + 0.21 = $0.98 Mil.
Total Current Assets was $25.74 Mil.
Total Assets was $111.31 Mil.
Property, Plant and Equipment(Net PPE) was $17.30 Mil.
Depreciation, Depletion and Amortization(DDA) was $3.32 Mil.
Selling, General, & Admin. Expense(SGA) was $17.54 Mil.
Total Current Liabilities was $5.38 Mil.
Long-Term Debt & Capital Lease Obligation was $4.28 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(5.114 / 6.458) / (2.654 / 2.727)
=0.791886 / 0.973231
=0.8137

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0.976 / 2.727) / (2.357 / 6.458)
=0.357902 / 0.364974
=0.9806

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (9.155 + 23.617) / 94.687) / (1 - (25.735 + 17.302) / 111.306)
=0.653891 / 0.613345
=1.0661

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=6.458 / 2.727
=2.3682

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(3.316 / (3.316 + 17.302)) / (1.831 / (1.831 + 23.617))
=0.16083 / 0.071951
=2.2353

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(19.095 / 6.458) / (17.544 / 2.727)
=2.956798 / 6.433443
=0.4596

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((6.865 + 9.525) / 94.687) / ((4.279 + 5.38) / 111.306)
=0.173097 / 0.086779
=1.9947

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-28.57 - -8.543 - -10.845) / 94.687
=-0.096972

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Invictus MD Strategies has a M-score of -1.96 suggests that the company is unlikely to be a manipulator.


Invictus MD Strategies Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Invictus MD Strategies's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Invictus MD Strategies (Invictus MD Strategies) Business Description

Traded in Other Exchanges
N/A
Address
595 Burrard Street, 16th floor, Vancouver, BC, CAN, V7X 1J1
Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.

Invictus MD Strategies (Invictus MD Strategies) Headlines